Cargando…
Immunogenic Cell Death Induced by Ginsenoside Rg3: Significance in Dendritic Cell-based Anti-tumor Immunotherapy
Cancer is one of the leading causes of morbidity and mortality worldwide; therefore there is a need to discover new therapeutic modules with improved efficacy and safety. Immune-(cell) therapy is a promising therapeutic strategy for the treatment of intractable cancers. The effectiveness of certain...
Autores principales: | Son, Keum-joo, Choi, Ki ryung, Lee, Seog Jae, Lee, Hyunah |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Association of Immunologists
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4770102/ https://www.ncbi.nlm.nih.gov/pubmed/26937234 http://dx.doi.org/10.4110/in.2016.16.1.75 |
Ejemplares similares
-
Induction of immunogenic cell death of tumors by newly synthesized heterocyclic quinone derivative
por: Son, Keum-joo, et al.
Publicado: (2017) -
Effects of ginsenoside Rg3 on apoptosis in A375.S2 melanoma cells
por: Kim, Joo Hyoung, et al.
Publicado: (2019) -
Ginsenoside Rg1 and 20(S)-Rg3 Induce IgA Production by Mouse B Cells
por: Park, Ha-Yan, et al.
Publicado: (2015) -
Immunogenic cell death in cancer immunotherapy
por: Choi, Minji, et al.
Publicado: (2023) -
Upregulation of autophagy by Ginsenoside Rg2 in MCF-7 cells
por: Chung, Yuheon, et al.
Publicado: (2018)